Thymosin beta-4 promotes mesenchymal stem cell proliferation via an interleukin-8-dependent mechanism

Byung Joon Jeon, Yoolhee Yang, Su Kyung Shim, Heung Mo Yang, Dae Ho Cho, Sa Ik Bang

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Mesenchymal stem cells (MSCs) hold great promise for the field of tissue regeneration. Because only a limited number of MSCs can be obtained from each donor site, it is important to establish standard methods for MSC expansion using growth and trophic factors. Thymosin β4 (Tβ4) is a novel trophic factor that has antimicrobial effects and the potential to promote tissue repair. Tβ4 is a ubiquitous, naturally-occurring peptide in the wound bed. Therefore, the relationship between Tβ4 and MSCs, especially adjacent adipose tissue-derived stem cells (ASCs), merits consideration. Exogenous Tβ4 treatment enhanced the proliferation of human ASCs, resulting in prominent nuclear localization of PCNA immunoreactivity. In addition, exogenous Tβ4 also increased IL-8 secretion and blocking of IL-8 with neutralizing antibodies decreased Tβ4-induced ASC proliferation, suggesting that IL-8 is a critical mediator of Tβ4-enhanced proliferation. Moreover, Tβ4 activated phosphorylation of ERK1/2 and increased the nuclear translocation of NF-κB. These observation provide that Tβ4 promotes the expansion of human ASCs via an IL-8-dependent mechanism that involves the ERK and NF-κB pathways. Therefore, Tβ4 could be used as a tool for MSC expansion in cell therapeutics.

Original languageEnglish
Pages (from-to)2526-2534
Number of pages9
JournalExperimental Cell Research
Volume319
Issue number17
DOIs
Publication statusPublished - 2013 Oct 15
Externally publishedYes

Fingerprint

Thymosin
Mesenchymal Stromal Cells
Interleukin-8
Cell Proliferation
Adipose Tissue
Stem Cells
thymosin beta(4)
Proliferating Cell Nuclear Antigen
Neutralizing Antibodies
Regeneration
Intercellular Signaling Peptides and Proteins
Phosphorylation
Observation

Keywords

  • Cell proliferation
  • ERK pathway, NF-κB
  • Interleukin-8
  • Mesenchymal stem cells
  • Thymosin β4

ASJC Scopus subject areas

  • Cell Biology

Cite this

Thymosin beta-4 promotes mesenchymal stem cell proliferation via an interleukin-8-dependent mechanism. / Jeon, Byung Joon; Yang, Yoolhee; Kyung Shim, Su; Yang, Heung Mo; Cho, Dae Ho; Ik Bang, Sa.

In: Experimental Cell Research, Vol. 319, No. 17, 15.10.2013, p. 2526-2534.

Research output: Contribution to journalArticle

Jeon, Byung Joon ; Yang, Yoolhee ; Kyung Shim, Su ; Yang, Heung Mo ; Cho, Dae Ho ; Ik Bang, Sa. / Thymosin beta-4 promotes mesenchymal stem cell proliferation via an interleukin-8-dependent mechanism. In: Experimental Cell Research. 2013 ; Vol. 319, No. 17. pp. 2526-2534.
@article{3c1fcd7f048440b48f826e1e36a364c9,
title = "Thymosin beta-4 promotes mesenchymal stem cell proliferation via an interleukin-8-dependent mechanism",
abstract = "Mesenchymal stem cells (MSCs) hold great promise for the field of tissue regeneration. Because only a limited number of MSCs can be obtained from each donor site, it is important to establish standard methods for MSC expansion using growth and trophic factors. Thymosin β4 (Tβ4) is a novel trophic factor that has antimicrobial effects and the potential to promote tissue repair. Tβ4 is a ubiquitous, naturally-occurring peptide in the wound bed. Therefore, the relationship between Tβ4 and MSCs, especially adjacent adipose tissue-derived stem cells (ASCs), merits consideration. Exogenous Tβ4 treatment enhanced the proliferation of human ASCs, resulting in prominent nuclear localization of PCNA immunoreactivity. In addition, exogenous Tβ4 also increased IL-8 secretion and blocking of IL-8 with neutralizing antibodies decreased Tβ4-induced ASC proliferation, suggesting that IL-8 is a critical mediator of Tβ4-enhanced proliferation. Moreover, Tβ4 activated phosphorylation of ERK1/2 and increased the nuclear translocation of NF-κB. These observation provide that Tβ4 promotes the expansion of human ASCs via an IL-8-dependent mechanism that involves the ERK and NF-κB pathways. Therefore, Tβ4 could be used as a tool for MSC expansion in cell therapeutics.",
keywords = "Cell proliferation, ERK pathway, NF-κB, Interleukin-8, Mesenchymal stem cells, Thymosin β4",
author = "Jeon, {Byung Joon} and Yoolhee Yang and {Kyung Shim}, Su and Yang, {Heung Mo} and Cho, {Dae Ho} and {Ik Bang}, Sa",
year = "2013",
month = "10",
day = "15",
doi = "10.1016/j.yexcr.2013.04.014",
language = "English",
volume = "319",
pages = "2526--2534",
journal = "Experimental Cell Research",
issn = "0014-4827",
publisher = "Academic Press Inc.",
number = "17",

}

TY - JOUR

T1 - Thymosin beta-4 promotes mesenchymal stem cell proliferation via an interleukin-8-dependent mechanism

AU - Jeon, Byung Joon

AU - Yang, Yoolhee

AU - Kyung Shim, Su

AU - Yang, Heung Mo

AU - Cho, Dae Ho

AU - Ik Bang, Sa

PY - 2013/10/15

Y1 - 2013/10/15

N2 - Mesenchymal stem cells (MSCs) hold great promise for the field of tissue regeneration. Because only a limited number of MSCs can be obtained from each donor site, it is important to establish standard methods for MSC expansion using growth and trophic factors. Thymosin β4 (Tβ4) is a novel trophic factor that has antimicrobial effects and the potential to promote tissue repair. Tβ4 is a ubiquitous, naturally-occurring peptide in the wound bed. Therefore, the relationship between Tβ4 and MSCs, especially adjacent adipose tissue-derived stem cells (ASCs), merits consideration. Exogenous Tβ4 treatment enhanced the proliferation of human ASCs, resulting in prominent nuclear localization of PCNA immunoreactivity. In addition, exogenous Tβ4 also increased IL-8 secretion and blocking of IL-8 with neutralizing antibodies decreased Tβ4-induced ASC proliferation, suggesting that IL-8 is a critical mediator of Tβ4-enhanced proliferation. Moreover, Tβ4 activated phosphorylation of ERK1/2 and increased the nuclear translocation of NF-κB. These observation provide that Tβ4 promotes the expansion of human ASCs via an IL-8-dependent mechanism that involves the ERK and NF-κB pathways. Therefore, Tβ4 could be used as a tool for MSC expansion in cell therapeutics.

AB - Mesenchymal stem cells (MSCs) hold great promise for the field of tissue regeneration. Because only a limited number of MSCs can be obtained from each donor site, it is important to establish standard methods for MSC expansion using growth and trophic factors. Thymosin β4 (Tβ4) is a novel trophic factor that has antimicrobial effects and the potential to promote tissue repair. Tβ4 is a ubiquitous, naturally-occurring peptide in the wound bed. Therefore, the relationship between Tβ4 and MSCs, especially adjacent adipose tissue-derived stem cells (ASCs), merits consideration. Exogenous Tβ4 treatment enhanced the proliferation of human ASCs, resulting in prominent nuclear localization of PCNA immunoreactivity. In addition, exogenous Tβ4 also increased IL-8 secretion and blocking of IL-8 with neutralizing antibodies decreased Tβ4-induced ASC proliferation, suggesting that IL-8 is a critical mediator of Tβ4-enhanced proliferation. Moreover, Tβ4 activated phosphorylation of ERK1/2 and increased the nuclear translocation of NF-κB. These observation provide that Tβ4 promotes the expansion of human ASCs via an IL-8-dependent mechanism that involves the ERK and NF-κB pathways. Therefore, Tβ4 could be used as a tool for MSC expansion in cell therapeutics.

KW - Cell proliferation

KW - ERK pathway, NF-κB

KW - Interleukin-8

KW - Mesenchymal stem cells

KW - Thymosin β4

UR - http://www.scopus.com/inward/record.url?scp=84885373263&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84885373263&partnerID=8YFLogxK

U2 - 10.1016/j.yexcr.2013.04.014

DO - 10.1016/j.yexcr.2013.04.014

M3 - Article

VL - 319

SP - 2526

EP - 2534

JO - Experimental Cell Research

JF - Experimental Cell Research

SN - 0014-4827

IS - 17

ER -